- medical school: University of Bombay, India
- fellowship: Louisiana State University Medical Center (pediatric hematology/oncology)
- fellowship: University of Michigan (pediatric hematology/oncology)
- residency: Louisiana State University Medical Center
alpha thalassemia, hemoglobinopathies and children, Hemoglobin E or E beta thalassemia, sickle cell disease, thalassemia
Dr. Mukund G. Dole is a pediatric hematologist-oncologist at Dayton Children’s Hospital and an Associate Professor of Pediatrics at Boonshoft School of Medicine, Wright State University. He is program director of the West Central Ohio Comprehensive Sickle Cell Center in Dayton.
Dr. Dole obtained his medical degree from the University of Bombay and received his General Pediatrics training at Childrens Hospital of Louisiana and LSU Medical Center, New Orleans, LA. He completed his fellowship in Pediatric Hematology- Oncology at the University of Michigan, Ann Arbor, MI. He is board certified in both General Pediatrics and Pediatric Hematology-Oncology.
Besides being a general hematologist-oncologist, Dr. Dole has a special interest and expertise in management of patients with sickle cell disease and other related hemoglobin disorders. Along with other members of his department, he remains an active participant in clinical trials conducted by Childrens Oncology Group (COG) for managing children with cancer.
Scheduling in-person appointments for new patients only.
If your child is an existing patient, log in to MyKidsChart to schedule directly with your provider for follow up care.
Alpha thalassemia, Anemia, Astrocytoma, Bleeding disorders, Blood clotting disorders, Bone cysts, Bone marrow transplant, Bone tumors and sarcomas, Brain and spinal cord tumors, Brain tumors, Cancers of the blood, Cartilage tumors, Congenital amegakaryocytic thrombocytopenia, Cyclic neutropenia, Desmoplastic small round cell tumors, Dysfunctional uterine bleeding, Dyskeratosis congenita, Ependymoma, Fanconi anemia, Fibrosarcoma’s, G6PD deficiency, Germ cell tumors, Glioma, Hamartomas, hemoglobinopathy, Hemangiomas, Hemoglobin E or E beta thalassemia, Hemophilia, Hemostasis disorders, Hepatoblastomas, Hepatocellular carcinomas, Hereditary spherocytosis, Hodgkin's lymphoma, Immune thrombocytopenic purpura (ITP), Kidney tumors, Langerhans cell histiocytosis, Leukemia, Liver tumors, Lymphomas, Medulloblastoma, Melanomas, Neuroblastoma, Neurocutaneous disorders, Neurofibromas, Neurofibromatosis (NF) FF1, NF2, and Schwannomatosis, Neutropenia, Osteosarcomas, Peripheral nerve sheath tumor, Platelet disorders, Pyruvate kinase deficiency, Red blood cell disorders, Retinoblastoma, Rhabdomyosarcoma, Sarcomas, Severe congenital neutropenia (Kostmann's syndrome), Shwachman-Diamond syndrome, Sickle cell disease, Solid tumors of the bones, Solid tumors of the organs, Solid tumors of the tissues, Spinal tumors, Sturge-Weber disease, Synovial sarcoma, Thalassemia, Thrombocytopenia, congenital or acquired, Thrombocytosis, Thrombophilia, Thrombosis, Thyroid cancer, Transient erythroblastopenia of childhood (TEC), Tuberous sclerosis, Undifferentiated sarcoma of the liver, Vascular anomalies, Vascular malformation, Von Willebrand disease, White blood cell disorders, Wilms Tumor, hemoglobinopathy